Spots Global Cancer Trial Database for Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Official Title: A Biobehavioral Intervention for Patients With Gynecologic or Breast Cancer Recurrence

Study ID: NCT01764789

Interventions

questionnaire administration

quality-of-life assessment

psychosocial assessment and care

behavioral intervention

cognitive intervention

educational intervention

Study Description

Brief Summary: This pilot clinical trial studies stress reduction in improving quality of life in patients with recurrent gynecologic or breast cancer. Participating in a stress reduction program may help improve quality of life in patients with gynecologic or breast cancer.

Detailed Description: PRIMARY OBJECTIVES: I. To refine the intervention. II. Test the acceptability, feasibility, and clinical appropriateness of the intervention. III. To provide a preliminary test of its efficacy. OUTLINE: Patients participate in a multi-component intervention based on cognitive and behavioral principles comprising mindfulness-based stress reduction (MBSR), an intervention to promote hopefulness, and a problem solving approach which navigates around obstacles or generates alternatives when goals become blocked. Additional topics may be covered as indicated by clinical need and patients goals. Biobehavioral components include addressing social and disease-specific quality of life, and pain education. Intensive treatment sessions continue weekly for 16 weeks followed by 2 biweekly and 2 monthly maintenance sessions. After completion of study treatment, patients are followed up at 28 weeks.